Crispr Therapeutics Ag (CRSP)

Deferred Revenue

$15.19M

Quarterly · Period ending: · USD

CRSP logo

CRSP Deferred Revenue

Latest reported$15.19M
CRSP Quarterly Deferred Revenue ($0.00 → $15.19M)
High-resolution chart · PNG

CRSP deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
15,189,000
15,344,000
15,771,000
1,295,000
2,129,000
3,021,000
3,845,000
4,483,000
4,759,000
4,072,000
4,105,000
3,500,000
0
0
0
0
0
0
1,010,999
1,562,000
2,071,000
1,802,000
2,341,000
610,000
759,000
803,000
960,000
47,725,000
0
0
0
0
0
0
0
0
0
0
0
63,608,000
63,608,000
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.